Form 4 for IRMD IRADIMED CORP
Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-05 · accession 0000898432-21-000723 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-10 | 2021-11-05+ | IRMD | HAWKINS JAMES B | Dir | A - Grant | $1.48 | +16.2K | 22.8K | +247% | +$24.0K |
| DM | 2021-11-10 | 2021-11-05+ | IRMD | HAWKINS JAMES B | Dir | S - Sale | $38.64 | -16.2K | 17.3K | -48% | -$626.5K |
| DM | 2021-11-10 | 2021-11-05+ | IRMD | HAWKINS JAMES B | Dir | M - OptEx | $0.00 | -16.2K | 90.0K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-09 | A | A | 1,234 | $1.48 | 18,502 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 2 | Common | Common Stock | 2021-11-08 | S | D | 9,479 | $38.98 | 17,268 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $38.60 to $39.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-11-08 | A | A | 9,479 | $1.48 | 26,747 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 4 | Common | Common Stock | 2021-11-05 | S | D | 5,501 | $38.25 | 17,268 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $38.25 to $38.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2021-11-05 | A | A | 5,501 | $1.48 | 22,769 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 6 | Common | Common Stock | 2021-11-09 | S | D | 1,234 | $37.75 | 17,268 | D | — | — | |
| 7 | Derivative | Stock Options (Right to Buy) | 2021-11-05 | M | D | 5,501 | $0.00 | 100,713 | D | $1.48 · — to 2023-12-31 | 5,501 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 8 | Derivative | Stock Options (Right to Buy) | 2021-11-08 | M | D | 9,479 | $0.00 | 91,234 | D | $1.48 · — to 2023-12-31 | 9,479 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 9 | Derivative | Stock Options (Right to Buy) | 2021-11-09 | M | D | 1,234 | $0.00 | 90,000 | D | $1.48 · — to 2023-12-31 | 1,234 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |